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Schizophrenia is a chronic and disabling mental disease.
It is characterized by a complex of positive and negative
symptoms associated with marked social and occupa-
tional dysfunction. There are four main phases of the dis-
ease: the acute phase, the resolving phase, the stable phase
and the relapse phase. Most patients come to the clinic in
the acute phase which is, often, characterized by agitation,
hostility, positive symptoms and catatonic signs. The goal
of therapy is the rapid reduction in the agitation and
aggression. Conventional antipsychotics have been, for
many years, the mainstay of treatment in the acute schiz-
ophrenic patient. Rapid neuroliptization was a commonly
used strategy to control agitation and florid psychotic
symptoms. Drugs were titrated until clinical improvement
was observed. However, the last years, the use of this
method has declined. Higher doses were associated with
more neurological side-effects and clinical response was
no greater than that seen with moderate doses. Nowadays,
atypical antipsychotics (alone or in combination with
benzodiazepines) are recommended as the first-line treat-
ment in acute schizophrenia. These drugs have been
shown to be as effective as conventional antipsychotics
regarding positive symptoms with a much better safety
profile, particularly with respect to motor side-effects. Risk
factors for relapse include psychosocial stressors, sub-
stance abuse and discontinuation of the antipsychotic
medication. The goals of the maintenance treatment are
to maintain or to further improve symptoms remission,
achieve psychosocial reintegration, improve quality of life
and prevent relapse.
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